WHO ICTRP trial
Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies after…
EUCTR2021-006172-16-AT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2021-006172-16-AT |
|---|---|
| Public title | Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies after COVID-19 Booster Vaccines – The CoVVacBoost Study - The CoVVacBoost Study |
| Scientific title | Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies after COVID-19 Booster Vaccines – The CoVVacBoost Study - The CoVVacBoost Study |
| Primary sponsor | Medical University of Graz |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Austria |
| Conditions | Covid (Coronavirus disease)- 19 immunisation MedDRA version: 23.1 Level: PT Classification code 10084457 Term: COVID-19 immunisation System Organ Class: 10042613 - Surgical and medical procedures ;Therapeutic area: Body processes [G]… |
| Interventions | Trade Name: Comirnaty concentrate for dispersion for injection Pharmaceutical Form: Concentrate for solution for injection INN or Proposed INN: COVID-19 mRNA Vaccine Other descriptive name: COVID-19 mRNA vaccine (nucleoside-modified)… |
| Registration date | Nov 16, 2021 |
| Target size | 1200 |
| Secondary IDs | CoVVacBoost |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: